Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Richard J. Jones, MD

LICENSE # 0101273509
 
Issue Date: 10/30/2021
Expiration Date: 7/31/2026
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 9/22/2022
None Reported
Academic Appointments - Non-US
Last Updated 9/22/2022
Sidney Kimmel Comprehensive Cancer Center
Rank: Director of BMT program
Years: 1994-present
Publications
(up to ten in the last five years)
Last Updated 9/22/2022
Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial
Lancet Haematol
2022 (9):e660-e669. doi: 10.1016/S2352-3026(22)00206-X
Date: 07 2022

HLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score matching and donor age.
Blood Adv
6(14):4335-4346. doi: 10.1182/bloodadvances.2022007741, 2022. PMID: 35613462.
Date: 07 2022

The next horizon now that everyone has a donor: Precision allogeneic transplantation
Blood Rev.
14:100990. doi: 10.1016/j.blre.2022.100990.
Date: 07 2022

Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy
Leuk Lymphoma
4:1-7. doi: 10.1080/10428194.2022.2057488, 2022
Date: 08 2022

Mismatched donor transplantation with post-transplantation cyclophosphamide for advanced cutaneous T-cell lymphoma: a single-center retrospective study
Leuk Lymphoma
1:1-5. doi: 10.1080/10428194.2022.2105330
Date: 08 2022